Potential Drug Target/Biomarker: ZBTB44-DT (G646383)

Target Name: ZBTB44-DT

NCBI ID: G646383

ZBTB44-DT

Other Name(s): Uncharacterized LOC646383, transcript variant X6 | LOC646383 variant X6 | ZBTB44 divergent transcript

Potential Drug Target/Biomarker: ZBTB44-DT

ZBTB44-DT (Uncharacterized LOC646383, transcript variant X6) is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZBTB44-DT is a transcription factor, which has been shown to play a role in regulating gene expression and has been linked to the development and progression of various diseases.

Disease-related function

ZBTB44-DT has been shown to be involved in the regulation of gene expression that is associated with disease progression. For example, ZBTB44-DT has been shown to be involved in the regulation of the expression of genes that are involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Additionally, ZBTB44-DT has also been shown to be involved in the regulation of gene expression that is associated with cancer, such as the regulation of the expression of genes involved in the development and progression of breast cancer.

Potential drug target

The potential drug target for ZBTB44-DT is based on its involvement in the regulation of gene expression that is associated with disease progression and the potential to target genes involved in disease-related processes.

ZBTB44-DT has been shown to play a role in the regulation of gene expression that is associated with the development and progression of various diseases, including cancer and neurodegenerative diseases. Therefore, it is a potential drug target for diseases that are characterized by the uncontrolled regulation of gene expression, such as cancer and neurodegenerative diseases.

Biomarker

ZBTB44-DT has also been shown to be a potential biomarker for various diseases, including cancer and neurodegenerative diseases. This is because the regulation of gene expression by ZBTB44-DT is associated with the development and progression of these diseases. Therefore, the levels of ZBTB44-DT in biological tissues or biological fluids can serve as potential biomarkers for these diseases.

In addition, the regulation of gene expression by ZBTB44-DT is also associated with the uncontrolled regulation of gene expression, which is a hallmark of cancer. Therefore, ZBTB44-DT may also be a potential biomarker for cancer.

Conclusion

ZBTB44-DT is a protein that has been shown to play a role in regulating gene expression that is associated with the development and progression of various diseases, including cancer and neurodegenerative diseases. Therefore, it is a potential drug target and biomarker for diseases characterized by the uncontrolled regulation of gene expression. Further research is needed to fully understand the role of ZBTB44-DT as a potential drug target and biomarker.

Protein Name: ZBTB44 Divergent Transcript

The "ZBTB44-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB44-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets